PB 109 of 2022
National Health (Closing the Gap—PBS Co‑payment Program) Special Arrangement Amendment (General Co‑payment) Instrument 2022
I, Elsy Brammesan, as delegate of the Minister for Health and Aged Care, make the following instrument.
Dated 15 December 2022
Elsy Brammesan
Acting Assistant Secretary
Pharmacy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
National Health (Closing the Gap – PBS Co‑payment Program) Special Arrangement 2016
(1) This instrument is the National Health (Closing the Gap—PBS Co‑payment Program) Special Arrangement Amendment (General Co‑payment) Instrument 2022.
(2) This instrument may also be cited as PB 109 of 2022.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 January 2023. | 1 January 2023 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under subsection 100(2) of the National Health Act 1953.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
National Health (Closing the Gap – PBS Co‑payment Program) Special Arrangement 2016
1 Section 10A
Before “A pharmaceutical”, insert “(1)”.
2 At the end of section 10A
Add:
(2) A supply of a pharmaceutical benefit under this Special Arrangement is not eligible for increased discounting within the meaning of section 87AA of the Act.
3 Paragraph 11(4)(b)
Omit “the general patient charge (without any allowable discount)”, substitute “$42.50 (without any allowable discount)”.